Biobank For MS And Other Demyelinating Diseases
This study is enrolling participants by invitation only.
Sponsor:
Accelerated Cure Project for Multiple Sclerosis
Information provided by:
Accelerated Cure Project for Multiple Sclerosis
ClinicalTrials.gov Identifier:
NCT00445367
First received: March 8, 2007
Last updated: March 5, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.
| Condition |
|---|
|
Multiple Sclerosis Transverse Myelitis Neuromyelitis Optica Acute Disseminated Encephalomyelitis Optic Neuritis |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control |
| Official Title: | Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases |
Resource links provided by NLM:
Further study details as provided by Accelerated Cure Project for Multiple Sclerosis:
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls.
Criteria
Inclusion Criteria:
- age 18+ able to give informed consent or individuals younger than 18 with parental permission and able to give assent
- willing to provide up to 110 ml (50 ml for < 18 years old) of blood via venipuncture
- experienced at least one CNS demyelinating event characteristic of MS, TM, NMO, ADEM, or ON
Exclusion Criteria:
- history of blood borne pathogens
- allogeneic bone marrow transplant
- clinical or radiological evidence of stroke, meningitis, or other well characterized diseases of the nervous system (with the exception of MS, TM, NMO, ADEM, or ON).
- weight less than 37 pounds
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00445367
Locations
| United States, Arizona | |
| Barrow Neurological Institute | |
| Phoenix, Arizona, United States, 85013 | |
| United States, California | |
| Stanford University | |
| Stanford, California, United States, 94305 | |
| United States, Colorado | |
| The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver | |
| Aurora, Colorado, United States, 80045 | |
| United States, Georgia | |
| Shepherd Center | |
| Atlanta, Georgia, United States, 30309 | |
| United States, Maryland | |
| Johns Hopkins | |
| Baltimore, Maryland, United States, 21287 | |
| United States, Massachusetts | |
| Beth Israel Deaconess | |
| Boston, Massachusetts, United States, 02215 | |
| University of Massachusetts Medical School | |
| Worcester, Massachusetts, United States, 01605 | |
| United States, New York | |
| Multiple Sclerosis Research Center of New York | |
| New York, New York, United States, 10019 | |
| United States, Ohio | |
| The Ohio State University | |
| Columbus, Ohio, United States, 43210 | |
| United States, Texas | |
| University of Texas Southwestern Medical Center at Dallas | |
| Dallas, Texas, United States, 76051 | |
Sponsors and Collaborators
Accelerated Cure Project for Multiple Sclerosis
Investigators
| Principal Investigator: | Benjamin Greenberg, M.D., M.H.S. | University of Texas |
More Information
Additional Information:
No publications provided
| ClinicalTrials.gov Identifier: | NCT00445367 History of Changes |
| Other Study ID Numbers: | ACP-001 |
| Study First Received: | March 8, 2007 |
| Last Updated: | March 5, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Accelerated Cure Project for Multiple Sclerosis:
|
Multiple Sclerosis Clinically Isolated Syndrome Transverse Myelitis Neuromyelitis Optica |
Acute Disseminated Encephalomyelitis Optic Neuritis Repository Biobank |
Additional relevant MeSH terms:
|
Demyelinating Diseases Encephalomyelitis, Acute Disseminated Encephalomyelitis Multiple Sclerosis Myelitis Myelitis, Transverse Neuritis Neuromyelitis Optica Optic Neuritis Sclerosis Nervous System Diseases Demyelinating Autoimmune Diseases, CNS Autoimmune Diseases of the Nervous System Leukoencephalopathies Brain Diseases |
Central Nervous System Diseases Autoimmune Diseases Immune System Diseases Encephalitis Central Nervous System Infections Central Nervous System Viral Diseases Virus Diseases Spinal Cord Diseases Paraneoplastic Syndromes, Nervous System Nervous System Neoplasms Neoplasms by Site Neoplasms Paraneoplastic Syndromes Neurodegenerative Diseases Peripheral Nervous System Diseases |
ClinicalTrials.gov processed this record on May 19, 2013